Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

Delayed Quote. Delayed  - 08/31 05:35:10 pm
20.75 GBp   --.--%
08/17 PURICORE : Granted Two US Patents For Skin Disorder Therapy Producti..
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
05/27 PURICORE : To Stop Selling ProduceFresh Until Registered As Pesticid..
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
08/24/2016 08/25/2016 08/26/2016 08/30/2016 08/31/2016 Date
20.75(c) 20.75(c) 20.75(c) 20.75(c) 20.75 Last
0 0 0 3 250 0 Volume
-1.19% 0.00% 0.00% 0.00% 0.00% Change
More quotes
Company
PuriCore Plc engages in the development and provision of water-based clean technology decontamination solutions.It operates through the following Supermarket Retail and Health Science segments.The Supermarket Retail segment provides products extending the shelf life of fresh produce.The Health... 
More about the company
Latest news on PURICORE PLC
08/17 PURICORE : Granted Two US Patents For Skin Disorder Therapy Production
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
05/27 PURICORE : To Stop Selling ProduceFresh Until Registered As Pesticide
04/14 PURICORE : Appointment of Dr. Christian Peters as Chief Medical Officer
04/14 PURICORE : Appoints Christian Peters As Chief Medical Officer
03/29 PURICORE : CEO Buys 100,000 Shares (DIRECTOR DEALINGS)
03/29 PURICORE : Good progress
03/29 PURICORE : Good progress Biopharmaceutical company PuriCore,
03/24 PURICORE : Considers Spin-Off Of Supermaket Retail Unit As Revenue Rises
03/01 PURICORE : Appoints Balkrishan Gill To Board As Non-Executive
More news
Sector news : Biotechnology & Medical Research - NEC
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/29DJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart PURICORE PLC
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Full-screen chart
Managers
NameTitle
John Alexander Martin Chief Executive Officer & Executive Director
Charles Alexander Evan Spicer Non-Executive Chairman
Marella Thorell COO, CFO, Secretary & Executive Director
Christian Peters Chief Medical Officer
Joseph William Birkett Senior Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PURICORE PLC5.06%14
INCYTE CORPORATION-25.33%15 224
CELLTRION, INC.--.--%11 086
LONZA GROUP AG14.41%10 067
QUINTILES TRANSNATIONA..12.35%9 140
ALKERMES PLC-44.62%6 662
More Results